| 5-FU | 5-fluorouracil |
| APC | Adenomatous Polyposis Coli |
| APC | antigen-presenting cell |
| BMP | bone morphogenetic protein |
| BMPR2 | BMP receptor type 2 |
| CAF | cancer-associated fibroblast |
| CCL | C-C motif chemokine ligand |
| CDC | cell-division cycle |
| CMS | consensus molecular subtype |
| Co-SMAD | common-mediator SMAD |
| CRC | colorectal cancer |
| CTLA4 | cytotoxic T lymphocyte antigen 4 |
| CXCL | C-X-C motif chemokine ligand |
| dMMR | mismatch repair deficiency |
| EMT | epithelial to mesenchymal transition |
| FOXP3 | forkhead box P3 |
| GDF15 | growth differentiation factor-15 |
| GEMM | genetically-engineered mouse model |
| IL | interleukin |
| INFγ | interferon-γ |
| I-SMAD | inhibitory SMAD |
| JAK | Janus kinase |
| LOH | loss of heterozygosity |
| MAPK | mitogen-activated protein kinase |
| MDSC | myeloid-derived suppressor cells |
| MHC | major histocompatibility complex |
| MLH | MutL homolog |
| MMP | matrix metalloproteinase |
| MSC | mesenchymal stem cell |
| MSH | MutS homolog |
| MSI | microsatellite instability |
| MSI-H | high level of MSI |
| PCR | polymerase chain reaction |
| PD1 | programmed cell death 1 |
| PI3K | phosphoinositide 3-kinase |
| PIK3CA | PI3K catalytic subunit-α |
| PMS | Postmeiotic segregation increased |
| R-SMAD | receptor-regulated SMAD |
| ROCK | Rho-associated protein kinase |
| SMAD | Caenorhabditis elegans SMA and Drosophila MAD |
| STAT | signal transducer and activator of transcription |
| TAM | tumor-associated macrophages |
| TAN | tumor-associated neutrophils |
| TCR | T-cell receptor |
| TGFβ | Transforming growth factor-beta |
| TGFBR2 | TGFβ receptor type 2 |
| TH1 | type 1 T-helper cell |
| TNFα | tumor necrosis factor-α |
| T-reg | regulatory T-cell |
| VEGF | vascular endothelial growth factor |